Topchoice Medical
Topchoice Medical
Topchoice Medical Investment Corp. provides medical services.
Topchoice Medical, founded in August, 1995 and headquartered in Hangzhou, is a company providing oral medical and assisted reproductive services. The founder is Lu Jianming. Listed on the SSE on October 30, 1996, the company's major shareholders are Lu Jianming, Bao Zhengliang and Hong Kong Securities Clearing Co. Ltd. Rivals that have direct and indirect competition with Topchoice Medical include Huamei Dental, Bybo Dental, Envista, etc.
- All
- News
- Analysis
- Research
In-depth
Healthcare
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Briefing Oct 19, 2021 06:56 AM
· Financials
The investment banking business was strictly supervised, and seven securities companies received fines
Briefing Oct 17, 2021 06:26 PM
· Healthcare
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Briefing Oct 15, 2021 06:25 PM
· Healthcare
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Briefing Sep 17, 2021 11:58 AM
· Technology
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Healthcare
Dynamic Biosystems Snags Nearly CNY 100 Mn in Series A+
Dynamic Biosystems is a single cell and space multi-omics technology platform enterprise. The company focuses on exploring the huge potential in the fields of precision medicine of tumor, eugenics and fertility, and drug discovery, and is committed to promoting precision medicine to the era of single cell and space omics, helping life science and clinical medicine.
Feb 06, 2023 07:25 PM
Briefing Jul 20, 2021 01:18 AM
· Consumer Staples
Zhang Kun's four funds decreased their positions in the second quarter by allocating Wuliangye to Guizhou Maotai
Briefing Aug 04, 2020 10:46 AM
· Healthcare
TC Medical's 1H 2020 Revenue Totals CNY 738 Mn, Down 12.87% YoY
See more
Related Companies
